Log in to your Inderes Free account to see all free content on this page.
Infant Bacterial Therapeutics
53.90 SEK
-3.75 %
Less than 1K followers
IBT B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Infant Bacterial Therapeutics
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -33.6 | -37.2 | -144.5 | -17.5 | -19.9 | -10.6 | -20.1 | -68.2 |
| EBIT | -33.8 | -37.4 | -145.3 | -17.5 | -20.1 | -10.8 | -20.5 | -69.0 |
| EBIT-% | ||||||||
| Profit before taxes | -32.7 | -33.8 | -136.9 | -16.7 | -19.2 | -10.1 | -19.2 | -65.2 |
| Net income | -32.7 | -33.8 | -136.9 | -16.7 | -19.2 | -10.1 | -19.2 | -65.2 |
Login required
This content is only available for logged in users